Volume 85, Issue 4 p. 370
Free Access

Erratum

First published: 20 September 2010

The proteasome inhibitor bortezomib inhibits FGF-2-induced reduction of TAZ levels in osteoblast-like cells. Eur J Haematol 2010 85(1):68–75. Epub 2010 Feb 23

The labels ‘RANK’ and ‘RANKL’ in Figure 4 of the article are reversed. The label ‘RANKL’ should be on the surface of ‘Immature-Obl’, and the label ‘RANK’ should be on ‘Pre-Ocl’ instead.

The authors apologize that they did not notice the error during the proof revisions.

    The full text of this article hosted at iucr.org is unavailable due to technical difficulties.